Microlax 4's 5 ml solution for rectal application

The instruction for medical use of MIKROLAKS medicine the Trade name of Mikrolaks the International unlicensed name Is not present the Dosage form Solution for rectal use of 5 ml Structure 1 ml of solution contains: active agents: sodium citrate – 90.0 mg, sodium laurylsulphoacetate of 70% – 12.9 mg (9 mg of sodium of laurylsulphoacetate are equivalent), sorbitol liquid (crystallizing) – 893.0 mg (625.0 mg of sorbitol are equivalent) excipients: sorbic acid, glycerin, water purified. The description the Colourless, viscous solution containing small vials of air. Pharmacotherapeutic group Laxatives. Laxative drugs in enemas. Sodium laurylsulphoacetate, including in a combination with other drugs. ATX A06AG11 code the Pharmacological MIKROLAKS Pharmacokinetics properties – the combined drug having laxative effect. The effect occurs in 15 min. A pharmacodynamics laurylsulphoacetate (dilutes intestines contents) and sorbite are a part of drug citrate (peptizator which forces out the connected water which is contained in stool), sodium of sodium (strengthens laxative action by stimulation of water inflow in intestines). Increase in an amount of water due to peptization and fluidifying promotes softening of stool and facilitates bowel emptying. Indications the Constipation, including with enkoprezy, preparation to endoscopic (rektoskopiya) and to X-ray inspection of digestive tract. The route of administration and doses Adults and children are more senior than 3 years: to enter contents of one microclyster (5 ml) rektalno, inserting a tip at all length. Newborns and children up to 3 years: to enter contents of one microclyster rektalno, inserting a tip on a half of length (see a mark in a tip). If complaints remain for a long time, it is necessary to see a doctor. Instructions on use Break off a seal on a tube tip. Slightly press on a tube so that the drop of drug greased an enema tip – it will facilitate introduction process. At use of microclysters on 5 ml at children up to 3 years enter an enema tip into a rectum on a half of length, after 3 years enter an enema tip into a rectum entirely. Squeezing a tube, squeeze out completely its contents. Take a tip, still slightly squeezing a tube. Side effects according to spontaneous messages about the undesirable phenomena the Undesirable reactions arising against the background of drug use which were revealed during post-registration use were classified as follows: very frequent (≥10%), frequent (≥1%, but & lt, 10%), not frequent (≥0.1%, but & lt, 1%), rare (≥0.01%, but & lt, 0.1%), very rare (& lt, 0.01%) and undesirable reactions with an unknown frequency of emergence (frequency of emergence cannot be estimated on the basis of the available data). Very seldom: pain in a stomach (including abdominal discomfort, pain in a stomach and also in upper abdomens), discomfort in anorectal area, a liquid chair, reactions of hypersensitivity (for example, a small tortoiseshell). Contraindications Hypersensitivity to active substances or to any excipients as a part of drug, an abdominal pain of not clear genesis, impassability of intestines. Medicinal interactions there Is a risk of developing necrosis of a large intestine at simultaneous oral/rectal administration of sodium of the polystyrene sulphonate and sorbitol which is a part of drug. Special instructions At preservation of symptoms in order to avoid prolonged use of drug it is necessary to see a doctor. Prolonged use of a microclyster can lead to irritation of anal pass. Drug use is not recommended to patients with inflammation or an ulceration of a large intestine (hemorrhoids, anal cracks, ulcer colitis, etc.). In the presence at the patient of exacerbation of gastrointestinal diseases it is necessary to use drug with care. Drug treatment of constipations is addition to lifestyle and a dietotherapy (proteinaceous diet, sufficient water consumption, physical activity). When using at children age less than three years a tip should be entered on a half of length. For simplification of introduction the greasing of a tip is recommended by a small amount of contents of a tube. If medicine became useless or the expiration date expired – do not pour out it in sewage and do not throw out on the street! Place medicine in a package and put in a garbage container. These measures will help to protect the environment! The feature of influence of medicine on ability to run the vehicle or potentially the MIKROLAKS dangerous mechanisms does not influence ability to control of vehicles and control of mechanisms. Pregnancy and a lactation Adequate and strictly controlled researches with participation of pregnant women were not conducted. As this drug is probably soaked up in a system blood stream in insignificant degree, at its use according to recommendations during pregnancy or a lactation the development of undesirable effects for a fruit or the baby is not expected. The overdose is not described the Form of release and packing On 5 ml of drug place in the microclysters for single use representing a tube from polyethylene of the low density (LDPE) with a tip and the breaking-off seal. On 4 or 12 microclysters together with the instruction for medical use in the state and Russian languages place in a cardboard pack. To Store storage conditions at a temperature not above 25 °C to Store out of children's reach. A period of storage 3 years Prescription status Without prescription the Producer Famar Orlean, avenue de Consir, 5, 45071 of Orlean Sedex 2, France the Owner of the registration certificate of LLC Johnson & Johnson, Moscow, Krylatskaya St., 17, building 2, Russian Federation the Address of the organization accepting claims from consumers on quality of products (goods) and responsible for post-registration observation of safety of medicine in the territory of the Republic of Kazakhstan LLC Johnson & Johnson Branch in Republic of Kazakhstan 050040, Republic of Kazakhstan, Almaty, Timiryazev St., 42, pavilion 23-A